The Rwanda Biomedical Centre (RBC) has officially announced a Call for Applications for its Master's Scholarship under the Malaria Molecular Surveillance (MMS) Project, offering an outstanding opportunity for ambitious students passionate about malaria research, public health, and disease control.
Funded by the Bill & Melinda Gates Foundation, this three-year initiative aims to strengthen Rwanda's capacity to monitor malaria by establishing a National Malaria Molecular Surveillance Platform and a National Malaria Reference Genomics Laboratory. The project will support real-time detection of antimalarial drug resistance and diagnostic resistance markers, contributing to Rwanda's efforts toward malaria elimination.
Scholarship Fields
Eligible applicants can apply for Master's studies in the following disciplines:
- Biomedical Laboratory Sciences
- Biotechnology
- Bioinformatics
- Biostatistics
- Health Financing
- Pharmacy
- Other related Health Sciences
Why Apply?
Successful candidates will have the opportunity to:
- Participate in cutting-edge malaria research.
- Contribute to Rwanda's national malaria surveillance efforts.
- Build advanced laboratory, genomics, and data analysis skills.
- Work alongside leading researchers and public health experts.
- Support Rwanda's goal of eliminating malaria through innovative scientific approaches.
Who Should Apply?
The scholarship is ideal for motivated graduates who:
- Have a strong interest in malaria control and elimination.
- Wish to pursue a Master's degree in health-related disciplines.
- Are committed to research, innovation, and public health.
- Meet the admission requirements for the selected academic program.
Application Deadline
Deadline: 7 August 2026
Interested applicants are encouraged to submit their applications before the deadline.
How to Apply
Applicants can access the application portal and detailed eligibility requirements through the official RBC scholarship application link provided in the announcement.
About the Malaria Molecular Surveillance Project
The Malaria Molecular Surveillance (MMS) Project is a national initiative led by the Rwanda Biomedical Centre to strengthen the country's capacity for monitoring malaria parasites using modern molecular technologies. By improving surveillance systems and genomic analysis, the project will enable faster identification of drug-resistant malaria strains and support evidence-based public health interventions
Post a Comment